The DOJ announced on September 26, 2018 that they had entered into a settlement with KinderCare regarding administering insulin via pen or syringe to children with type 1 diabetes. Under the agreement, KinderCare is obligated to take critical steps toward improving access for children with Type 1 diabetes, including revising its policies and procedures, revising its training, and performing initial and ongoing assessments of the need for reasonable accommodations. Click here for more information.